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Background: PQS (Pseudomonas Quinolone Signal) and its precursor HHQ are signal molecules of the P. aeruginosa
quorum sensing system. They explicate their role in mammalian pathogenicity by binding to the receptor PqsR that
induces virulence factor production and biofilm formation. The enzyme PqsD catalyses the biosynthesis of HHQ.
Results: Enzyme kinetic analysis and surface plasmon resonance (SPR) biosensor experiments were used to
determine mechanism and substrate order of the biosynthesis. Comparative analysis led to the identification of
domains involved in functionality of PqsD. A kinetic cycle was set up and molecular dynamics (MD) simulations
were used to study the molecular bases of the kinetics of PqsD. Trajectory analysis, pocket volume measurements,
binding energy estimations and decompositions ensured insights into the binding mode of the substrates
anthraniloyl-CoA and β-ketodecanoic acid.
Conclusions: Enzyme kinetics and SPR experiments hint at a ping-pong mechanism for PqsD with ACoA as first
substrate. Trajectory analysis of different PqsD complexes evidenced ligand-dependent induced-fit motions
affecting the modified ACoA funnel access to the exposure of a secondary channel. A tunnel-network is formed in
which Ser317 plays an important role by binding to both substrates. Mutagenesis experiments resulting in the
inactive S317F mutant confirmed the importance of this residue. Two binding modes for β-ketodecanoic acid were
identified with distinct catalytic mechanism preferences.Background
Quorum sensing (QS) is a chemical cell-to-cell commu-
nication system in bacteria ruled by small extracellular
signal molecules. It coordinates the social life of bacteria
by regulating many group-related behaviours, such as
biofilm formation and virulence factor production [1-5].
Anti-QS has been recognized as an attractive strategy in
the fight against bacteria [6] based on anti-virulence and
anti-biofilm action and not on bacterial killing.
The opportunistic Gram-negative pathogen P. aeruginosa
is a good model to study the complexity of QS systems
[1,4]. At least three distinct QS pathways are known which
regulate in a hierarchical manner the QS-dependent target* Correspondence: matthias.negri@helmholtz-hzi.de
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reproduction in any medium, provided the orgene expression. The first two QS systems, las [7] and
rhl [8], utilize N-acyl homoserine lactones (C4- and C12-
AHL) and the receptors LasR and RhlR [9]. The third
QS-system is 2-alkyl-4-hydroxyquinoline (HAQ)-dependent
and specific for P. aeruginosa and some Burkholderia
strains [10-12]. PQS (Pseudomonas Quinolone Signal)
and to a lesser extent its precursor HHQ (2-heptyl-4-
hydroxyquinoline) activate PqsR [13-15].
A key enzyme of the PQS biosynthesis pathway is PqsD
(PQB biosynthetic 3-oxoacyl-[acyl-carrier-protein] [ACP]
synthase III; EC 2.3.1.180), which catalyses the formation
of HHQ by “head-to-head” decarboxylative condensa-
tion of anthranilate (as anthraniloyl-CoA; ACoA) and
β-ketodecanoic acid (βK) [16,17].
Several groups have proven that P. aeruginosa pqsD
knock-out mutant as well as PQS-deficient P. aeruginosa
strains have an attenuated pathogenicity in nematode
and mouse models evidencing the significance of PQSral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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PQS levels have been detected in lungs of cystic fibrosis
patients supportive for an active role of QS in chronic
lung infections [19-21]. These findings and in particular
the recent identification of the first class of PqsD inhibi-
tors that reduce biofilm and virulence factor formation
in P. aeruginosa validates PqsD as a target for the devel-
opment of anti-infectives [22].
PqsD is a homodimeric bi-substrate enzyme with high
structural similarity to FabH and other β-ketoacyl-[ACP]
synthases III (KAS III). They share a common thiolase
fold (αβαβα), a long tunnel to the active site, and the
same catalytic residues [23-25]. Three PDB structures of
PqsD exist [26]: as apoform (3H76), as Cys112-ligated
anthranilate (CSJ) complex with ACoA molecules in the
primary funnel (3H77) and as Cys112Ala mutant in
complex with anthranilic acid (3H78) [23]. In all three
structures the catalytic centre is accessible by two chan-
nels in L-shape: the primary CoA/ACP-funnel, and the
shorter secondary channel (Additional file 1: Figure. SI1).
However, the molecular details of ACoA access and, in
particular, the binding mode and the subsequent in-
corporation of βK are unknown.
Knowledge of the kinetics and of the conformational
flexibility of an enzyme can significantly contribute to a
successful rational drug design [27-29]. Herein we study
the molecular basis of PqsD and the HHQ biosynthesis
combining experimental and in silico methods. Enzyme
kinetic analysis and surface plasmon resonance (SPR)
biosensor experiments were used to determine the
mechanism and the substrate order of the biosynthesis;
comparative analysis of PqsD to homologous KAS-III
enzymes was useful to identify domains specific for
PqsD functionality. Molecular dynamics (MD) simula-
tions were carried out to explore the binding modes of
ACoA and βK as well as the conformational flexibility
of PqsD.
Results and discussion
Knowledge of enzyme kinetics for multi-substrate reac-
tions is helpful to set up and interpret MD simulations.
We performed biochemical and biophysical studies to
determine the underlying kinetic mechanism of PqsD.
Biochemical and biophysical characterization hint at
ping-pong kinetic mechanism of PqsD
Enzyme kinetic studies were performed using a 96-well
format-based in vitro assay with the purified enzyme PqsD
to determine the kinetic parameters for each substrate.
Optimum enzymatic reaction conditions were determined
in advance. Plotting product formation versus time re-
vealed that a reaction time of 4 min in combination with
an enzyme concentration of 0.25 μM was suitable and that
values in linear range within the progress curve could beobtained (data not shown). The initial velocity (v) was cal-
culated by dividing the product concentration by the reac-
tion time. Plotting the data with GraphPad Prism 5
software resulted in an array of parallel lines in the
Lineweaver-Burk-Plot and a common Y-axis-intercept in
the Hanes-Woolf-Plot (Figure 1A and 1B). This suggests a
ping pong kinetic mechanism for PqsD as described also
for other Claisen condensing enzymes [30]. The results
were in agreement with reported mass spectrometric
[31], structural [23], and surface plasmon resonance
(SPR) based [32] studies revealing the formation of an
anthraniloyl-PqsD intermediate with concomitant re-
lease of the first product CoA before binding of the sec-
ond substrate β-ketodecanoic acid (βK).
The KM data (ACoA 0.875 ±0.140 μM, βK 1300 ±
158 μM) correlate well with the KD values determined
with SPR by our group (ACoA 1.08 μM, βK 2.95 mM)
[32]. Also, the kinetic parameters, derived mutually
varying both substrates (Figure 1C) and fitting the data
with the ping-pong Equation (1) are within the range of
the apparent values determined by Pistorius et al.
(KM app,ßK = 598.5 ± 106 μM; Vmax = 495.8 ± 37.5 fmol
HHQ/min/pmol PqsD; kcat (PqsD as monomer) = 0.01 s
-1).
v ¼ Vmax ACoA½ 
KmACoAþ ACoA½  1þ Km βKβK½ 
   (1) [33] SPR bio-
sensor assays were performed to assess the influence of
substrate addition order on the HHQ product formation.
Firstly, as recently reported [32], PqsD was immobilized to
the SPR chip and ACoA injected; the increase in the
response-line preserved also after washing was an indi-
cator for the covalent linkage of anthraniloyl to Cys112
(Figure 1D and Additional file 1: SI1). The subsequent
addition of βK displaced the anthraniloyl from Cys112
with HHQ formation as confirmed by mass spectrometry
(see supporting information Text SI2). Strikingly, repeat-
ing the experiments with inverted substrate order (βK
first, then ACoA) resulted in less than half of HHQ forma-
tion (Additional file 1: Figure SI2A) supportive for the
preferential substrate order deducible from the kinetic
analysis of the HHQ biosynthesis. However, the latter find-
ing cannot be excluded to be at least in part due to sub-
strate inhibition. The different plots of the kinetic data
and the “inverted” SPR experiments sustain the idea that
PqsD follows a ping-pong kinetic mechanism with ACoA
as the first substrate (Figure 1E). Based on these results a
putative kinetic cycle for HHQ biosynthesis was set-up
and different PqsD-ligand complexes chosen to simulate
the single steps (Additional file 1: Figure. SI2B).Comparative analysis
PqsD and KAS III enzymes are structurally similar, but
they diverge in their biosynthesis pathways. Differences
in the amino acid sequence of the active sites might
Figure 1 Ping-pong kinetic mechanism of PqsD in HHQ biosynthesis. A) Lineweaver-Burk Plot and B) Hanes-Woolf Plot representing the
activity of PqsD as a function of ACoA concentration in the presence of 60 (diamonds), 120 (black circles), 240 (triangles), 480 (open squares) and
1000 μM (open circles) ßK. All data are mean values of four replicates. C) Kinetic parameters of PqsD. D) “Real-time” PqsD kinetics by SPR
experiments: 1. ACoA injection; 2. buffer run - response units remain high due to anthranilate-Cys112; 3. βK injection; 4. Buffer run – response line
goes to zero due to HHQ formation and restored apo PqsD. E) Schematic view of the putative ping-pong kinetic mechanism of the HHQ
biosynthesis (E - PqsD, ECSJ - PqsD with Cys112-ligated anthranilate).
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performed against the Uniprot and the PDB database.
The closest homologues were FabH2 of several patho-
genic Burkholderia strains (~55% sequence identity)
and FabHs of Gram-positive and Gram-negative bac-
teria (~29-40% sequence identity). A multiple sequence
alignment of PqsD with these enzymes was performed
using Probcons [35] with Jalview [36] (Additional file 1:
Figure. SI3-SI4). As seen in the sequence alignment all
these enzymes, but in particular PqsD and Burkholderia
FabH2, diverge in amino acid sequence in several re-
gions (Figure 2 and Additional file 1: SI3). The domain
that varies most in terms of sequence identity as well as
in 3D-folding is the dimer-interface, comprising hairpin
loop (hL; residues 185–220) and helixes H8-H9 (h8-9;
residues 143–160). Further, differences are found in
the “substrate-loop” (sL) and the adenosine binding do-
main (aBS).
As evident in PqsD and FabHs 3D-structures the sLs
border the active site and contribute in the formation ofa central cavity in the dimer structures, which is
surmounted by the hL helixes H11 and which can be
filled by water molecules (Figure 2 and Additional file 1:
SI1B). Mutagenesis studies in FabH showed that resi-
dues placed within this sL play an exceptional role for
the substrate specificity [37]: bulky residues (Phe87;
E. coli FabH - ecFabH) determine a clear preference for
the short-chained acetyl-CoA, smaller residues (Thr87;
M. tuberculosis FabH - mtFabH) account for a long-
chained substrate preference, such as lauroyl-CoA
[37-40]. PqsD and Burkholderia FabH2 both produce
HHQ and both share the same palindromic sequence
(−S82PDHHDPS89-) in the sL. According to the se-
quence alignment for PqsD and FabH2 we identified
Asp87 as positional analogue of ecFabH Phe87 and
mtFabH Thr87 (Figure 2); consequently, also, Asp87
might be involved in the substrate recognition process.
Mutagenesis studies on ecFabH showed that exchan-
ging basic residues surrounding the primary funnel
access to acid residues strongly affected CoA- and
Figure 2 Functionally important domains of PqsD. A) 3D structure of the PqsD dimer with functionally significant domains and the central
cavity. PqsD is rendered as cartoon with flexible regions coloured in green. Water molecules present in the central cavity are shown as
red spheres. B) Multiple sequence alignment of PqsD and homologous KAS-III enzymes. Abbreviations: Paer – Pseudomonas aeruginosa,
Bamb – Burkholderia ambifaria, Ecoli – Escherichia coli, Aael – Aquifex aeolicus, Tther – Thermus thermophilus, Saur – Staphylococcus aureus,
Efaec – Enterococcus faecalis, Sliv – Streptomyces lividans, Mtub – Mycobacterium tuberculosis.
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corresponding residues are negatively charged or neu-
tral (i.e. Glu227, Glu269, Gln270; violet triangle),
which is reflected on a tertiary structure level in a
modified electrostatic potential surface (Additional file 1:
Figure SI5). The access to the primary funnel of PqsD
is surrounded by basic residues, in part not present
in other FabHs, forming a large “cationic belt” (i.e.
Arg36, Arg151, Arg153, Arg221, Arg223, Arg262).
This basic network forms part of the CoA and ACP
binding site [31].Molecular dynamics simulations (A-F) of the main steps of
the kinetic cycle
MD simulations of nine PqsD complexes A-F were
performed to elucidate the dynamic motions within the
HHQ kinetic cycle and the binding modes of ACoA and
βK. The volume variations of the primary funnels, sec-
ondary channels and central cavity were tracked using
the software fpocket2 [42] (Table 1). Finally, binding
free energy differences (ΔGbind) for ACoA, βK and
HHQ were estimated following a single-trajectory ap-
proach using MM-GBSA methodology (only enthalpy
Table 1 Internal pockets volume variations
MD code Central cavity Primary funnel (chain A) Primary funnel (chain B) Secondary channel (chain A) Secondary channel (chain B)
B 375-250 < 400-350 ≤ 475-500 ≥ 250 = 325-125 <
C1 375-500 > 400-530 > 450 = 300 = 400-150 <
C2 375 = 350-400 ≥ 475 = 250-300 ≥ 300-400 >
D 425-350 < 350-400 ≥ 375-300 < 200-350 > 400 =
E1 475-400 < 400-325 < 500-675 > 300 = 400-275 <
E2a 375-400 ≥ 400-525 > 500-300 < 300 = 400 =
E2b 300-400 > 400-450 ≥ 450-500 ≥ 250-300 ≥ 275-375 >
F 400 = 425-300 < 450-525 > 200-150 ≤ 275-300 ≥
Summary of the volume profiles (in Å3) over the time for central cavity, primary funnels and secondary channels of chain A and B for each simulation B-F tracked
with fpocket2. The trend progression of the volume is summarized as follows: decrease (<), modest decrease (≤), constant (=), modest increase (≥), increase (>).
The time-dependent volume-profiles are added in supplementary information as Figure. SI10.
MD codes: B – PqsD apoform, C1 – PqsD-ACoA in chain B, C2 – PqsD with ACoA in the primary funnel of chain A and B, D – PqsD with Cys112-bound anthranilate
(PqsD-CSJ), E1 - PqsD-CSJ with βK in the primary funnel of chain B, E2a - PqsD-CSJ with βK in the secondary channel of chain A, E2b - PqsD-CSJ with βK in the
secondary funnel of chain A and B, F – PqsD with HHQ in the primary funnel of chain B.
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binding free energy decomposition analysis to high-
light relevant residues for ligand binding. As two bind-
ing sites exist in the PqsD dimer we also inquired,
whether synergistic effects resulted for ΔGbind compar-





E_GAS EGB ΔGbind STD
C1 PqsD + ACoA (chain B)
−308 196 −111 14
C2 PqsD + ACoA (chain A)
−32 −50 −82 8
PqsD + ACoA (chain B)
25 −88 −63 7
E1 PqsD-CSJ + single βK, primary funnel (chain A)
−44 17 −27 2.5
E2a PqsD-CSJ + single βK, secondary channel (chain A)
15 −42 −27 6
E2b PqsD-CSJ + βK in secondary channel (chain A)
−7 −37 −44 5
PqsD-CSJ + βK in secondary channel (chain B)
6 −32 −26 6
F PqsD + HHQ (chain B)
−54 14 −40 3
STD. - standard deviation; E_GAS - binding energy in vacuum, EGB - binding
energy in implicit solvent computed with GB method.
ΔGbind (kcal/mol) are computed for ACoA, βK and HHQ in the different PqsD
complexes describing the kinetic cycle: C1 – PqsD with ACoA in chain B, C2 –
PqsD with ACoA in the primary funnel of chain A and B, D – PqsD with Cys112-
bound anthranilate (PqsD-CSJ), E1 - PqsD-CSJ with βK in the primary funnel of
chain B, E2a - PqsD-CSJ with βK in the secondary channel of chain A, E2b -
PqsD-CSJ with βK in the secondary funnel of chain A and B, F – PqsD with
HHQ in the primary funnel of chain B.(E2b) to their single ligand counterparts (C1 and E2a
respectively).
Flexibility of PqsD as monomer or dimer. We investi-
gated the flexibility of PqsD submitting monomer A of the
apoform structure 3H76 to the HingeProt [43] and the
HingeMaster [44] web-servers. Both predictions indicate
the existence of hinges at the N- (G185/T195) and the
C-terminal end (M220/G222) of the hL capable of large
conformational changes (Additional file 1: Figure SI6A-C;
morphing the transition from closed to open hL con-
former using the Yale Morph Server [45]; Additional file 2:
Movie S1: video representing hinge opening and closing).
A more realistic measure of the PqsD flexibility is obtained
from the monomer (A) and, especially, the dimer PqsD
apoform MD simulations (B): in the monomer MD
very large fluctuations are observed for the hL (Figure 3;
green line), which collapses closing the secondary channel
(Additional file 1: Figure SI7A). In the dimer MD, on con-
trary, hL and sL of both chains sustain each other with
only the C-terminal β-sheet of the hL moving out thus ex-
posing the secondary channel access. The hinge predic-
tions and the motions seen for these MD simulations
evidence the flexible nature of the hL and suggest an im-
portant role for it in PqsD functionality.
Accounting for all the MD simulations (B-F) a rather
broad conformational ensemble was gathered. Thereby,
most of the fluctuations were located in the upper third
of PqsD (Additional file 1: Figure SI7B) in regions also
found disordered in several FabH crystal structures. This
implies that conformational rearrangements in any of
them can significantly impact on the functioning of the
enzymes. The most flexible domain in all the MD simu-
lations is the dimer interface including hL and h8-9
(Additional file 1: Figure SI8).
The refolding of the two hL helixes H11 and of h8-9
affected the dimer interface morphology (yellow dotted
circle – cavities at 0 ns, yellow full circle – cavities at
Figure 3 Residue-dependent RMS fluctuations of the apoform MD simulations with PqsD in its monomeric and dimer state. The
fluctuations of the residues of PqsD in its monomer form (MD code A) are coloured in green, whereas for the PqsD in its dimer state (MD code
B) chain A and B are shown in blue and red respectively. Domains putatively involved in the catalysis as identified by comparative analysis with
homologous KAS-III enzymes are labelled with their abbreviations (dotted orange box indicates helix H14): adenosine binding site - aBS,
palindromic “substrate-loop” - sL, helix H8-H9 loop - h8-9, hairpin-loop - hL, helix H12 - h12, “oxyanion-loop” – oL. Notably, also for all other MD
simulations the largest RMS fluctuations were found in these areas (see also Additional file 1: Figure SI8).
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rounding the primary funnel access (“cationic belt”;
Additional file 1: Figure SI9). Thereby, deep channels are
formed towards the central cavity (for apoform B,
single-ACoA C1 and the CSJ-PqsD D simulations) or
opening out into the secondary channel (for simulations
with βK in the secondary channel E2a-E2b; Figure 4).
In the apoform trajectory B the enzyme floats between
different conformers. On contrary, in presence of the
different substrates the equilibrium is selectively shifted
toward one preferred structure. This is reflected in theFigure 4 Conformational changes at dimer interface in the
dual-βK MD simulation E2b. Top view of the dimer interface at
30 ns with the secondary channel solvent-exposed (dotted yellow
eclipse) and the βK molecules shown as green surfaces. The dashed
green line indicates a cleft which exists between the two H11
helixes at 0 ns, but that disappears over the simulation run. The full
yellow circles indicate additional grooves formed at the interface.
The cyan arrows indicate the primary funnel accesses for
both chains.volume variations of internal cavities and channels
(Table 1 and Additional file 1: Figure SI10). In particular,
tracking the central cavity volume of the MD simula-
tions B-F resulted in a sinusoidal, “heart-beat”-like
volume-profile (Table 1): in the apoform simulation (B)
the volume is reduced; in the single-ACoA complex
(C1) the cavity volume increases; with two ACoA mole-
cules (C2) as well as for the CSJ-PqsD (D) complex the
cavity volume decreases. Finally, in the single-βK E2a
and, in particular, in the dual-βK simulations E2b the
volume increased. The formation of channels from the
central cavity into the oxyanion site (close to Asp87 and
Ser317), sideways out to the surface, or up to the dimer
interface suggests that water molecules might move
along these channels depending on the catalytic needs.
The fact that ligand-induced structural changes are
observed in the very same regions in presence of diverse
ligands makes us confident that a sufficiently large con-
formational ensemble has been gathered by the MD
simulations to represent a good starting point for
structure-based drug design and virtual screening. A
good example is represented by the motions of Phe218,
which is located on the C-terminal β-sheet of the hL of
each monomer (Additional file 1: Figure SI11): in the
MDs with ACoA C1 and C2, with CSJ D, with βK in the
primary funnel E1, and with HHQ F (chain B) it stays
turned towards the catalytic centre occluding the access
from the catalytic site to secondary channel and dimer
interface. On contrary, when βK is in the secondary
channel (E2b and chain A of E2a) Phe218 rotated out-
wards increasing the distance between the centre of
mass of Phe218 and the Cα of Cys112 (Additional file 1:
Figure SI11); the secondary channel opened out to the
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When no ligand is present in the catalytic centre (e.g. in
the apoform MD B and in chain A of F), an intermediate
position can be observed indicative for the conform-
ational flexibility of this area.
ACoA progression into the catalytic site
The simulations with ACoA supplemented well the
PqsD crystallographic data. In particular for the single-
ACoA simulations C1 ACoA moved deep into the pri-
mary funnel ending in a pose where the anthranilic ring
overlaps well with the Cys112-bound anthranilate of the
PDB-ID 3H77 structure (Figure 5 and SI12). Strikingly,
only Cys112, His257, and Asn287 of the monomer
hosting ACoA (chain B) assumed an ideal geometry for
catalysis (e.g. Cys112-His257 ~4 Å; initial/final distances
in Additional file 1: Figure SI12B). Arg36, Arg153, andFigure 5 Binding mode of ACoA. A) Final poses of the
single-ACoA simulation C1 (cyan; 37 ns) and of the dual-ACoA
simulation C2 (green; 31 ns) are superimposed with the PDB
structure 3H77 (ACoA orange - starting position; anthranilate-Cys112
in magenta – overlaps with ACoAC1). Phe32, Arg153, Asn154,
Phe218, His257, Asn287 and Ser317 of the single-ACoA simulation at
37 ns are shown as dark cyan sticks. B) Decomposed energy
contributions per residue (at least for one MD >0.5 kcal/mol)
determined by MM-GBSA methods for the MD simulations C1 (cyan)
and C2 (chain A – red; chain B – black).Arg223 showed the highest binding energy contributions
due to interactions with the phosphate groups of the
pantetheine-linker. As obvious from the decomposed en-
ergy contributions (Figure 5B) also Thr28, Phe32, Cys112,
Asn154, Leu155, Ile157, Leu158, Leu193, Phe218, Met220,
Gly222, Met225, Phe226, His257, Pro259, Asn260, Ile263,
Asn287, Ala289, Tyr315, and Ser317 contribute to ACoA
binding. The optimal position reached by ACoA in the
simulation C1 is also reflected in a more favourable esti-
mated ΔGbind (−111 kcal/mol; chain B) than for the two
ACoA molecules of the dual-ACoA simulation C2
(−82 kcal/mol, chain A; -63 kcal/mol, chain B). Strikingly,
plotting ΔGbind-versus-time shows a progressively more
favourable ΔGbind for C1 (Additional file 1: Figure SI13),
whereas for the two ACoAs in C2 the ΔGbind remain ra-
ther constant indicative for an equilibrated system, in
which, however, the ACoAs in C2 do not reach a
catalysis-like position (see distances in Additional file 1:
Figure SI12C). This hints at a sequential ACoA entrance/
release mechanism, where the empty monomer refolds
while binding of the first ACoA.
Where and how does βK bind in PqsD?
Our SPR experiments showed that using free βK acid as
second substrate yields higher HHQ formation than when
it is added first. The active site of PqsD PDB structures
seems inadequate to handle βK-(ACP) binding and βK-
incorporation [23]. However, in PqsD a secondary channel
exists similar to that of mtFabH, which can host long-
chained β-keto-acids (i.e. lauroyl-CoA) [40]. The access to
this channel is lined by polar residues (Arg145, Thr195,
Ser317, and Asp87 of the second monomer), whereas its
bottom part is rather hydrophobic (Leu81, Leu142,
Leu155, Leu159, Leu193, Met194, Phe218 and Met220).
Further, this secondary channel borders the central cavity
and the dimer interface with the ion-pair Asp87-Arg145
(of the other chain) and Phe218 acting as barrier respect-
ively. As PqsD is clearly capable of HHQ biosynthesis con-
formational changes are expected, in analogy to mtFabH
[46], that allow HHQ formation and release.
We followed two approaches to determine the most
plausible access path and binding mode of βK. In the first,
we docked βK into the primary funnel of anthranilate-
ligated PqsD. Two main orientations resulted: 1) with the
polar head of βK pointing to the catalytic triad (Additional
file 1: Figure SI14A); and 2) turned 180° with the carbox-
ylic group interacting with the Arg of the cationic belt.
The second binding mode was not supportive for any of
the catalytic mechanisms [10,17].
The second approach was based on the substrate size
similarity and the structural homology between PqsD
and mtFabH. We superimposed the Cys112-anthranilate
PqsD (PDB-ID 3H77) and mtFabH co-crystallized with
dodecyl-CoA (PDB-ID 1U6S) [46] and then transposed
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structure into βK in the secondary channel of PqsD
(Additional file 1: Figure SI14B). Active site refinement
with the LigX module of MOE [47] with restrained βK
resulted in an energy optimized complex with small Cα
RMSD (~ 1 Å) compared to the starting complex. This
second binding mode of βK looks similar to that
obtained by Bera et al. [23] for decanethiol by superim-
posing PqsD with the mtFabH structure PDB-ID 2QO1
where the decanethiol is covalently attached to the cata-
lytic Cys.
The MD simulations E1-E2b with βK either in the pri-
mary or in the secondary channels were supportive to
understand the putative ping-pong kinetic cycle.
MD simulation CSJ-PqsD with βK in the primary fun-
nel of chain B (E1; 34 ns): Only small conformational
changes are observed in this MD simulation for βK,
which points the 3-oxo-β-keto moiety towards the
catalytic triad (Additional file 1: Figure SI15). Thereby,
the carboxylate head is trapped in a hydrogen-bond
network with His257 and Asn287 holding the β carbon
of βK close to the CSJ-sulphur as shown by their
favourable energy contributions (Additional file 1:
Figure SI15B). Additionally, van der Waals interactions
are formed between βK and Leu193, Met220, Met225,
Phe226, Pro259, Ile263, and Tyr315 (Additional file 1:
Figure SI15).Figure 6 Binding mode of βK in the secondary channel (MD simulatio
at 0 and 30 ns. βK at 0 and 30 ns is shown as purple sticks and as green b
at 30 ns and as orange lines at 0 ns. The red arrows indicate the conforma
PqsD in the MD simulation E2b; Phe218 flips out in presence of βK. B) Sch
acids are illustrated in purple and hydrophobic amino acids in green circle
and dotted lines. C) Decomposed energy contributions per residue (at leas
MD simulations E2a (cyan) and E2b (chain A – red; chain B – black).MD simulation CSJ-PqsD with βK in the secondary chan-
nel of chain A (E2a; 30 ns): After 30 ns the carboxylic moi-
ety of βK protruded into the catalytic centre within 4.5 Å
of the amine of CSJ, the hydroxy group of Ser317 and of
the oxyanion site formed by Gln111 and Ser317. Further,
βK forms a hydrogen bond with Thr195 as shown in
Figure 6. Phe218 was pushed outwards by βK in chain A
(Figure 6A and Additional file 1: Figure SI11), while in the
empty chain B Phe218 points towards the catalytic centre
(Additional file 1: Figure SI11), reducing the primary fun-
nel volume of chain B (Additional file 1: Figure SI10).
MD simulation CSJ-PqsD with βK in both secondary
channels (E2b; 30 ns): As seen comparing the single- and
the dual-ACoA MD simulations C1 and C2 (Additional
file 1: Figure SI17 and SI18) simulating two βK molecules
simultaneously resulted in a more stable trajectory
(smaller RMSD as for E2a; Additional file 1: Figure SI21
and SI22). Still, the modelled presence of βKs in the sec-
ondary channels induce structural changes in the
dimer-interface and in neighbouring domains (hL, h8-
9, h12 and oL of one monomer and sL of the other
monomer; Additional file 1: Figure SI22). Two long
U-shaped tunnels are formed, which connect primary
funnel access, catalytic site (with CSJ and βK in a pro-
ductive pose) and secondary channel access at the dimer
interface (Figure 7). The two βK are in a similar or even
more optimal pose (see βK in chain A) as described forns E2a and E2b). A) Superimposed snapshots of βK binding to PqsD
all and sticks respectively. Important residues are shown as cyan lines
tional shift from the initial (yellow) to the final (blue) conformation of
ematic representation of βK in the secondary channel. Polar amino
s. Hydrogen bonds and CH-pi interactions are shown as green arrows
t for one MD >0.5 kcal/mol) determined by MM-GBSA methods for the
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(Figure 6A and SI11) exposing the secondary channels
of chain A and B to the dimer-interface (Figure 4).
Hydrogen bonds are formed between the carboxylic
moiety of βK and the amine of CSJ and the hydroxy
group of Ser317. Further, a hydrogen bond is formed
between the β-keto carbonyl and Thr195 holding βK
close to the “substrate-loop” (sL) and in particular to
Pro88 and Asp87 (see binding energy contributions;
Figure 6C). Finally, Van der Waals interactions are
established between βK and Leu81, Pro88, Leu155,
Leu159, Leu193, Met194 and Phe218.
Catalytic mechanism and βK binding modes
In this study the free acid form of βK was used to test
HHQ biosynthesis. Two aspects have thus to be consid-
ered: firstly, the free βK-acid is unlikely to exist in bacteria
and its KD value in the millimolar range determined by
SPR and enzyme kinetics does not fit with the substantial
HHQ production in P. aeruginosa. Secondly, inverting the
substrate order in either the SPR or the enzyme kinetic
studies still yields HHQ formation, although substantially
decreased (see Additional file 1: Figure SI2A).
The final pose identified in the simulation E1 with βK
in the primary funnel hints at a potential βK-activation
via decarboxylation, which could occur either spontan-
eously or facilitated by His257 and Asn287 in analogy
to other KAS-III enzymes.24 This pose of βK fits well
with the decarboxylative Claisen reaction (Figure 8E).Figure 7 U-shaped channel network formed in presence of βK in the
access with the catalytic centre (large unfilled arrow), the secondary chann
presence of βK a tunnel is formed between Cys112-bound anthranilate (CSJ
supply (needed for catalysis) from the central cavity to the oxyanion site cl
shown to interact with βK (CSJ, T195, F218, R145, D87′, P88′) as cyan stic
solvent accessible surface is color-coded as follows: blue – positive electr
(−25 kcal/mol), white – neutral.However, both of the above-mentioned aspects argue
against this binding mode as the “in vivo” one: the
orientation of βK cannot match that of any thioester-
bound form needed for its delivery (Figure 8A), and, in
addition, no access to the catalytic site for ACoA as sec-
ond substrate is possible as long as βK is placed in the
primary channel as seen for E1 (Figure 8B).
Given the unlikeliness of free βK acid as “in vivo” sub-
strate other events must occur in HHQ biosynthesis,
such as involvement of PqsB and PqsC [31] or ACP-
thioester binding, which could reduce the activation en-
ergy or favour the kinetics. Holding true the ACP-
delivered βK, we notice that the binding site topology
and final orientation of βK in the secondary channel
(MDs E2a-E2b) does not disturb the access of ACoA
(Figure 8C) nor it precludes thioester-delivered βK
(Figure 8D). The interactions with CSJ112, Thr195, and
Ser317 found for E2a-E2b (see energy contributions in
Figure 6C) fit well with the imine/enamine mechanism
proposed by Diggle et al. [10] (Figure 8F). An equal or
even more favourable ΔGbind is estimated for the two βK
in the dual-βK simulation E2b (−44 kcal/mol – chain A, -
26 kcal/mol – chain B) as compared to ΔGbind of the
single-βK (−27 kcal/mol in E1; -27 kcal/mol in E2a)
(Table 2). This hints at a positive synergistic effect of the
simultaneous presence of two βK molecules in the second-
ary channels, which might facilitate conformational
changes necessary to accommodate βK in an energetically
favoured pose. In this regard, it is helpful to remembersecondary channel. The U-shaped channel connects primary funnel
el (thin arrow) and the dimer interface (large dotted arrows). In
) and the central cavity (dashed thin arrow) potentially used for water
ose to P88′. βK is shown as green ball and sticks, whereas residues
ks. For clarity the domains are labelled with their abbreviations. The
ostatic potential (+25 kcal/mol); red – negative electrostatic potential
Figure 8 Binding modes of βK and putative catalytic mechanisms of βK-incorporation. A) βK is placed in the primary funnel (blue tube) as
in the MD simulation E1: no space is left to host the thioester carrier CoA/ACP. B) The access of ACoA into the primary funnel is hindered with
βK in the pose as in A. C) βK is in the secondary channel (violet box) as in the MD simulations E2a and E2b: in the primary funnel space is
available to accommodate the thioester carrier CoA/ACP. D) ACoA can access the primary funnel with βK in this pose and transfer anthranilate to
Cys112. E) The Claisen condensation fits best as mechanism for βK incorporation for βK in the primary funnel. F) The imine/enamine formation is
the most plausible mechanism for βK incorporation when βK is in the secondary channel.
Figure 9 SPR sensograms of ACoA. When ACoA is injected with
PqsD wild-type fixed on the chip (black) an increase in the response
units is observed corresponding to the anthranilate transfer to
Cys112. Differently, when S317F PqsD mutant (red) is present on the
chip, no increase is observed.
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is formed, which enlarges the catalytic centre (Additional
file 1: Figure SI10), thus accounting for a putative intramo-
lecular cyclization in HHQ formation. Although no con-
clusive data exists all the above aspects let us favour the
secondary channel binding mode as the more probable.
Ser317Phe PqsD mutant
In the MD simulations Ser317 is involved in hydrogen
bonds with the carbonyl-group of ACoA (C1 and C2)
and with the carbonyl- or the carboxylic-moiety of βK
(E2a and E2b). To verify its importance we exchanged
Ser317 by site-directed mutagenesis into Phe and deter-
mined the catalytic activity by detection of the formed
HHQ using UHPLC-MS/MS. Under assay conditions
(0.1 μM enzyme, 5 μM ACoA, 70 μM βK) the mutant
produced less factor 700 HHQ compared to the wild
type. Tenfold higher enzyme concentration of the S317F
did not result in an increase in HHQ production indicat-
ing a complete abolishment of the catalytic functionality.
In order to understand at which stage of the kinetics
the S317F mutant disrupts the biosynthesis we per-
formed SPR experiments using S317F PqsD. Strikingly
no anthranilate transfer to Cys112 was detected (Fig-
ure 9) suggesting that substitution of Ser317 with Phe
already disrupts the first step of the kinetics. The close
vicinity of Ser317 to the catalytic site, however, makes it
questionable whether the very weak enzyme activity isdue to the rooted ability of S317F to form hydrogen
bonds, as suggested by the consistent binding energy
contributions of Ser317 in most of the MD simulations
with both ACoA and βK (Figure 5 and 6), or because of
the primary funnel being occluded by the newly intro-
duced aromatic ring.
Conclusions
In this work we elucidated some of the molecular bases
of HHQ biosynthesis. A putative ping-pong kinetic
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ments, which was substantiated by the preferred sub-
strate order (ACoA prior to βK) assessed by SPR. These
data were useful to set-up and analyse the MD simula-
tions, which aimed to unmask dynamic motions
governing PqsD functionality. MD simulations reveal a
kinetic-step dependent adaptation of PqsD to the di-
verse ligands, a favoured binding mode for βK in the
secondary channel, as well as an arginine-assisted pro-
gression of ACoA towards the catalytic site. Also,
Ser317 was identified as an important binder for ACoA
and βK, at least in part confirmed by the inactive S317F
PqsD mutant.
In general, SPR studies with PqsD mutants will be
helpful to determine the binding mode of inhibitors. Fi-
nally, the conformational ensemble retained from the
MD simulations will serve as valuable starting point for
structure-based design of PqsD inhibitors.
Methods
Production and purification of recombinant PqsD in E. coli
The overexpression and purification of PqsD as an N-
terminal His6-tagged fusion protein in E. coli BL21 (ʎDE3)
using the vector pET28b(+) -pqsD was performed as de-
scribed by Pistorius et al. [17]. To remove the His6-tag the
protein was subjected to thrombin cleavage performed at
16°C for 16 h in a 50 mM Tris–HCl buffer, pH 8.0,
containing 150 mM NaCl, 1 mM 2-ME, 2.5 mM CaCl2
and 1 unit thrombin per mg protein followed by a second
passage through the His Trap HP 5 column. The protein
was frozen in liquid nitrogen.
Preparation of S317F PqsD mutant
S317F PqsD mutant was generated using the QuikChange
Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA)
according to the manufacturer’s instructions using the
pET28b(+)/pqsD plasmid as template and the mutagenesis
primers 5′ GCTGGTCCTGACCTACGGTTTTGGCGC
GACCTGGGGCG 3′ and 5′CGCCCCAGGTCGCGCC
AAAACCGTAGGTCAGGACCAGC 3′. Plasmid DNA
was purified using the GenEluteTM HP Plasmid Miniprep
Kit (Sigma-Aldrich, St. Louis, MO) and sequenced to con-
firm the site-directed mutation.
Enzyme kinetic analysis
The PqsD catalysed formation of HHQ was analysed
using a UHPLC-MS/MS based assay performed in 96-
well microtiter plates (Greiner) using the method of
Pistorius et al. [17] with some modifications. First, the
purified enzyme PqsD (0.8 μM; in 50 mM MOPS,
pH 7.0, 0.016% (v/v) Triton X-100) was preincubated
without substrates for 5 min at 37°C. The reaction buffer
(15 μL; 50 mM MOPS, pH 7.0) and the substrates ACoA
(20 μL; concentrations: 2–40 μM) and ßK (20 μL;concentrations: 240–4000 μM) were added. The reaction
was started by the addition of preincubated enzyme
(25 μL; 0.8 μM) resulting in a total reaction volume of
80 μL with the following final concentrations: PqsD
0.25 μM, ACoA 0.5 - 10.0 μM and ßK 60–1000 μM, Tri-
ton X-100 0.005%, methanol 2%. The reaction was
stopped after 4 min at 37°C by adding 80 μL of metha-
nol containing 1 μM of the internal standard amitriptyl-
ine. For each sample, the reactions were performed in
quadruplicate. HHQ-formation was detected using
UHPLC-MS/MS according to method in supplementary
information (Additional file 1: Text SI1). Data were plot-
ted and analysed using GraphPad Prism 5 software.
Synthesis of Anthraniloyl-S-Coenzyme A thioester
(ACoA). ACoA was synthesized from isatoic anhydride
and coenzyme A (CoA) as described by Simon and
Shemin [48].
Synthesis of ethyl 3-oxodecanoate, 3-oxodecanoic acid
(β ketodecanoic acid), and of HHQ (2-heptylquinolin-4
(1H)-one). Synthesis as described by Lu et al. [49].
Surface Plasmon resonance (SPR)
SPR binding studies were performed using a Reichert
SR7000DC optical biosensors instrument (Reichert
Technologie, Depew, NY 14043 USA). HC1000m sen-
sor chips were purchased from Xantec Analytics
(Düsseldorf, Germany).
Immobilization of H6PqsD or H6PqsD S317F
Overexpression and purification of PqsD or of the S317F
PqsD mutant was performed as previously described
[32]. H6PqsD or H6PqsD S317F was immobilized on
HC1000m sensor chip using standard amine coupling
chemistry at 25°C analogous to the manufacturer’s in-
struction. H6PqsD or H6PqsD S317F was diluted into
10 mM sodium acetate (pH 4.5) to a concentration of
100 μg/mL and coupled to the surfaces with densities
between 15000 and 20000 RU.
Catalytic activity of PqsD
ACoA was diluted into running buffer to 10 μM.
β-ketodecanoate (βK) was dissolved in methanol to a
10 mM stock solution and diluted into running buffer to
20 μM. In the first experiment ACoA was injected for
5 min association and 10 min dissociation time, followed
by a 20 min injection of βK. In the second experiment
βK was added to the running buffer (100 μM in 50 mM
Tris, pH 8.0, 150 mM NaCl, 0.1% Triton X-100). The
ACoA-injection (10 μM for 5 min) followed when the
binding site was saturated, indicated by a stable baseline.
In all experiments the flow through was collected.
After ACoA addition CoA emission was detected
using UHPLC-MS/MS as reported elsewhere [32].
After addition of the second substrate (experiment
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CHCl3, evaporated and diluted in 50 μL MeOH. HHQ
formation was detected using UHPLC-MS/MS (see
Additional file 1: Text SI1).
SPR study with S317F PqsD mutant
For comparison of ACoA binding to PqsD wild- type
and to S317F PqsD mutant, the study was performed as
in the first experiment described above.
Computational methods
Docking of βK and HHQ. βK and HHQ were docked
each 50 times with GOLDv5.0 [50] using the GOLD
SCORE function [51]. The docking site was defined in-
cluding all residues within 9 Å of ACoA found in PDB
structure 3H77. Covalent ligated PqsD and apoform
PqsD were used to dock βK and HHQ, respectively. The
default GOLD parameters were used.
Simulation protocol
System setup was performed as follows for all simulated
systems. Atomic coordinates were taken from PDB-ID
3H76 for MD simulations A, B, C1, C2 and F, and from
3H77 for D, E1, E2a and E2b. Water molecules and ions
present in the crystals were removed. The protonation
states were determined at pH 7.4 with the Protonate3D
module of MOE and the enzyme complexes then mini-
mized using the MOE module ligX [47]. The solvated
systems were set up using the AMBER11 [52] program
xLeap with AMBER99SB force field [53]. A 9 Å pad of
TIP3P waters was added to solvate each system as octa-
hedral box. Neutralizing counter ions were added to
each system.
Parameters for ACoA, βK, HHQ and the Cys112-
bound anthranilate (CSJ) were determined using the
sqm routine of AmberTools1.5 [52]. For each ligand
AM1-BCC charges were computed. For ACoA and βK a
net charge of -3 and -1 was set, respectively. For CSJ,
which was taken from the PDB-ID 3H77, the Cys pa-
rameters were used as starting point followed by
parameterization with the sqm routine.
MD simulations were performed with the parallelized
PMEMD module of AMBER 11. The starting PqsD com-
plexes were minimized and equilibrated with the back-
bone atoms restricted by harmonic restraints of initially
10 kcal mol −1 Å–2 and then progressively reduced to 5,
2, 1 and 0 kcal/mol. The systems were heated to 300 K
in the canonical NVT ensemble (constant number of
particles, N; constant volume, V; constant temperature,
T) using a Langevin thermostat, with a collision fre-
quency of 3.0 ps−1 Å−2. Production runs were then made
for 30–37 ns duration in the NPT ensemble at 300 K.
As with the heating, the temperature was controlled
with a Langevin thermostat (but with a 1.0 ps−1 collisionfrequency). The time step used for all stages was 2 fs
and all hydrogen atoms were constrained using the
SHAKE algorithm [54]. Long-range electrostatics were
included on every step using the Particle Mesh Ewald
algorithm with a 4th order B-spline interpolation [55].MD analysis
B-factor, distances and RMSD time series were calcu-
lated using the cpptraj analysis tool of the AmberTools
1.5 package.
Structures were sampled at 20 ps intervals. RMSD
values were calculated for the enzyme, but also for each
of the following regions individually, facilitating the in-
terpretation of the data: adenosine binding site (aBS),
“substrate-loop” (sL), helix8-9 (h8-9), hairpin loop (hL),
helix 12 (h12), oxyanion loop (oL).Volume variations of internal cavities
The volume variations (Å) over the time (ns) for five
cavities in PqsD were tracked for all PqsD dimer MD
simulations using the software package fpocket2 [42].
All MD snapshots were superimposed using the Cα of
the apoform PDB-ID 3H76 as reference structure. De-
fault parameters for the identification of small cavities
and channels were used. All plots are added in supple-
mentary materials.MM-GBSA calculations
Binding energies ΔGbind for ACoA, βK and HHQ were
estimated by conventional MM-GBSA methods (Mo-
lecular Mechanic – General Born Surface Area) [56]
using snapshots of the simulations sampled every 30 ps.
Energy decomposition analyses with Generalized Born
solvent were performed with per-residue decomposition
and 1–4 interactions added to the electrostatic and Van
der Waals terms (idecomp = 2). More details to the
MM-GBSA method are in Additional file 1: Text_SI2.
A detailed description of the MD simulations A-F, cavity
volume variation-versus-time profiles (Additional file 1:
Figure SI7), time-dependent ΔGbind profiles (Additional
file 1: Figure SI10), and RMSD plots (Additional file 1:
Figure SI13-SI20) are added as additional data. The RMSD
analyses of the different regions helped to visualize mo-
tions in the MD simulations not visible from the all-atom
RMSD plots for the entire protein and complemented the
amino acid fluctuation analyses shown in Figure 3.Figures and plots
Plots were made with Origin 9 or Excel, while figures
with PyMOL [57] or MOE [47].
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Text SI2 - MM-GBSA theory. Text SI3 - Description of molecular dynamics
simulations A-F. Supplementary Information Figures. Figure SI1 - Structural
peculiarities of PqsD. Figure SI2 - HHQ biosynthesis follows a ping-pong
mechanism. Figure SI3 - Multiple sequence alignment of PqsD and
KAS III enzymes. Figure SI4 - Average distance tree from the ProconsWS
alignment. Figure SI5 - Electrostatic potential of PqsD (A) and E. coli FabH (B).
Figure SI6 - Predicted hinge regions in PqsD. Figure SI7 - PqsD flexibility in
the single monomer MD simulations A. Figure SI8 - Residue-dependent RMS
fluctuations for the MD simulations A-F. Figure SI9 - Conformational changes
of the cationic belt. Figure SI10 - Time-dependent volume variations of
internal cavities. Figure SI11 - Time-dependent distance variation between
Phe218 and Cys112. Figure SI12 - Progression of ACoA in the single-ACoA
MD simulation C1. Figure SI13 - Time-dependent variation of the
estimated binding free energy. Figure SI14 - Where does βK bind in
PqsD? Figure SI15 - Binding mode of βK in the MD simulation E1.
Figure SI16-S23 - Trajectory analysis of the MD simulations B-F.
Supplementary information References.
Additional file 2: Movie S1. The morphing from the closed to the
open hairpin-loop (hL) conformation is showed as result of the
YaleMorphServer. The file is in avi format.
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